Privileged structures: efficient chemical "navigators" toward unexplored biologically relevant chemical spaces.
暂无分享,去创建一个
[1] David R Spring,et al. Is synthesis the main hurdle for the generation of diversity in compound libraries for screening? , 2009, Expert opinion on drug discovery.
[2] S. Park,et al. Novel application of Leuckart-Wallach reaction for synthesis of tetrahydro-1,4-benzodiazepin-5-ones library. , 2007, Chemical communications.
[3] A. Hopkins,et al. Navigating chemical space for biology and medicine , 2004, Nature.
[4] Wolfgang H. B. Sauer,et al. Molecular Shape Diversity of Combinatorial Libraries: A Prerequisite for Broad Bioactivity , 2003, J. Chem. Inf. Comput. Sci..
[5] S. Park,et al. Solid-phase parallel synthesis of natural product-like diaza-bridged heterocycles through Pictet-Spengler intramolecular cyclization. , 2006, Journal of combinatorial chemistry.
[6] Jongmin Park,et al. Development of a Benzopyran‐Containing Androgen Receptor Antagonist to Treat Antiandrogen‐Resistant Prostate Cancer , 2010, ChemMedChem.
[7] David R Spring,et al. A strategy for the diversity-oriented synthesis of macrocyclic scaffolds using multidimensional coupling. , 2013, Nature chemistry.
[8] Brett M. Ibbeson,et al. Diversity-oriented synthesis as a tool for identifying new modulators of mitosis , 2014, Nature Communications.
[9] R. Mrak,et al. Microglia and neuroinflammation: a pathological perspective , 2004 .
[10] D. Swinney,et al. How were new medicines discovered? , 2011, Nature Reviews Drug Discovery.
[11] J. Vederas,et al. Drug Discovery and Natural Products: End of an Era or an Endless Frontier? , 2009, Science.
[12] X. García‐Mera,et al. Pyrimidine derivatives as potent and selective A3 adenosine receptor antagonists. , 2011, Journal of medicinal chemistry.
[13] K. Tracey,et al. Targeting HMGB1 in inflammation. , 2010, Biochimica et biophysica acta.
[14] Stuart L. Schreiber,et al. Stereoselective Synthesis of over Two Million Compounds Having Structural Features Both Reminiscent of Natural Products and Compatible with Miniaturized Cell-Based Assays , 1998 .
[15] K. Tracey,et al. HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.
[16] Stefan Wetzel,et al. Biology-oriented synthesis. , 2011, Angewandte Chemie.
[17] Stuart L Schreiber,et al. A planning strategy for diversity-oriented synthesis. , 2004, Angewandte Chemie.
[18] Y. Jo,et al. Antidiabetic and antiobesity effects of Ampkinone (6f), a novel small molecule activator of AMP-activated protein kinase. , 2010, Journal of medicinal chemistry.
[19] Stuart L Schreiber,et al. Skeletal diversity via a branched pathway: efficient synthesis of 29 400 discrete, polycyclic compounds and their arraying into stock solutions. , 2002, Journal of the American Chemical Society.
[20] David R Spring,et al. Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules. , 2010, Nature communications.
[21] Adam Nelson,et al. Natural products as an inspiration in the diversity-oriented synthesis of bioactive compound libraries , 2008, Natural product reports.
[22] B. Ho,et al. Inhibitors of monoamine oxidase. Influence of methyl substitution on the inhibitory activity of beta-carbolines. , 1968, Journal of pharmaceutical sciences.
[23] Craig M. Crews,et al. Targeting the undruggable proteome: the small molecules of my dreams. , 2010, Chemistry & biology.
[24] J. Casida,et al. Combinatorial synthesis of novel and potent inhibitors of NADH:ubiquinone oxidoreductase. , 2000, Chemistry & biology.
[25] Jongmin Park,et al. Discovery and target identification of an antiproliferative agent in live cells using fluorescence difference in two-dimensional gel electrophoresis. , 2012, Angewandte Chemie.
[26] J. Mason,et al. New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures. , 1999, Journal of medicinal chemistry.
[27] Michelle R. Arkin,et al. Small-molecule inhibitors of protein–protein interactions: progressing towards the dream , 2004, Nature Reviews Drug Discovery.
[28] M. Breuning,et al. Elevated TGFβ–Smad signalling in experimental Pkd1 models and human patients with polycystic kidney disease , 2010, The Journal of pathology.
[29] David R Spring,et al. Diversity-oriented synthesis: producing chemical tools for dissecting biology. , 2012, Chemical Society reviews.
[30] Jérôme Hert,et al. Quantifying Biogenic Bias in Screening Libraries , 2009, Nature chemical biology.
[31] R. Hicklin,et al. Synthesis of complex and diverse compounds through ring distortion of abietic acid. , 2014, Angewandte Chemie.
[32] D C Swinney,et al. Phenotypic vs. Target‐Based Drug Discovery for First‐in‐Class Medicines , 2013, Clinical pharmacology and therapeutics.
[33] R. Hicklin,et al. A ring-distortion strategy to construct stereochemically complex and structurally diverse compounds from natural products. , 2013, Nature chemistry.
[34] C. Avendaño,et al. Pictet Spengler-type reactions in 3-arylmethylpiperazine-2,5-diones. Synthesis of pyrazinotetrahydroisoquinolines , 2004 .
[35] L. Allen. Stem cells. , 2003, The New England journal of medicine.
[36] M. Block,et al. Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism , 2005, Progress in Neurobiology.
[37] Seung Bum Park,et al. A design strategy for drug-like polyheterocycles with privileged substructures for discovery of specific small-molecule modulators. , 2011, Chemical communications.
[38] Adam Nelson,et al. Synthesis of Natural-Product-Like Molecules with Over Eighty Distinct Scaffolds** , 2008, Angewandte Chemie.
[39] W. Guida,et al. The art and practice of structure‐based drug design: A molecular modeling perspective , 1996, Medicinal research reviews.
[40] Stuart L. Schreiber,et al. The small-molecule approach to biology , 2003 .
[41] Kevin J. Tracey,et al. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal , 2005, Nature Reviews Immunology.
[42] Seung Bum Park,et al. Diversity-oriented synthesis of privileged benzopyranyl heterocycles from s-cis-enones. , 2008, The Journal of organic chemistry.
[43] B. Stockwell. Chemical genetics: ligand-based discovery of gene function , 2000, Nature Reviews Genetics.
[44] N. Gray,et al. Discovery of EGFR selective 4,6-disubstituted pyrimidines from a combinatorial kinase-directed heterocycle library. , 2006, Journal of the American Chemical Society.
[45] H. Mario Geysen,et al. A guide to drug discovery: Combinatorial compound libraries for drug discovery: an ongoing challenge , 2003, Nature Reviews Drug Discovery.
[46] K. Suk,et al. A small molecule binding HMGB1 and HMGB2 inhibits microglia-mediated neuroinflammation. , 2014, Nature chemical biology.
[47] A. Myers,et al. A solid-supported, enantioselective synthesis suitable for the rapid preparation of large numbers of diverse structural analogues of (-)-saframycin A. , 2002, Journal of the American Chemical Society.
[48] R A Houghten,et al. Parallel array and mixture-based synthetic combinatorial chemistry: tools for the next millennium. , 2000, Annual review of pharmacology and toxicology.
[49] David J Newman,et al. Natural products as leads to potential drugs: an old process or the new hope for drug discovery? , 2008, Journal of medicinal chemistry.
[50] Y. Feng,et al. Use of biomimetic diversity-oriented synthesis to discover galanthamine-like molecules with biological properties beyond those of the natural product. , 2001, Journal of the American Chemical Society.
[51] Anthony E. Boitano,et al. Chemical control of stem cell fate and developmental potential. , 2011, Angewandte Chemie.
[52] Renato A. Bauer,et al. Biomimetic diversity-oriented synthesis of benzannulated medium rings via ring expansion , 2012, Nature chemical biology.
[53] S. Danishefsky,et al. Total synthesis of cribrostatin IV: fine-tuning the character of an amide bond by remote control. , 2005, Journal of the American Chemical Society.
[54] Tjelvar S. G. Olsson,et al. The thermodynamics of protein-ligand interaction and solvation: insights for ligand design. , 2008, Journal of molecular biology.
[55] Lorenzo Moroni,et al. Differential Response of Adult and Embryonic Mesenchymal Progenitor Cells to Mechanical Compression in Hydrogels , 2007, Stem cells.
[56] Peter G. Schultz,et al. A Stem Cell–Based Approach to Cartilage Repair , 2012, Science.
[57] Helen J. Mitchell,et al. Natural Product-like Combinatorial Libraries Based on Privileged Structures. 1. General Principles and Solid-Phase Synthesis of Benzopyrans , 2000 .
[58] J. Choi,et al. Phenotypic screening to identify small-molecule enhancers for glucose uptake: target identification and rational optimization of their efficacy. , 2014, Angewandte Chemie.
[59] L. Ulloa,et al. High-mobility group box 1 (HMGB1) protein: friend and foe. , 2006, Cytokine & growth factor reviews.
[60] Y. Chung,et al. Preparation of pilot library with tetrahydro-β-carboline alkaloid core skeleton using tandem intramolecular Pictet–Spengler cyclization , 2006 .
[61] H. Beug,et al. TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis , 1998, Current Biology.
[62] Alan L Harvey,et al. Natural products in drug discovery. , 2008, Drug discovery today.
[63] L. Sternbach. The benzodiazepine story. , 1983, Journal of psychoactive drugs.
[64] Dong-Sup Lee,et al. A potent small-molecule inducer of chondrogenic differentiation of human bone marrow-derived mesenchymal stem cells , 2012 .
[65] S. Masamune,et al. Total Synthesis of the L-Hexoses , 1983, Science.
[66] A. Mantalaris,et al. TGF-β3: A potential biological therapy for enhancing chondrogenesis , 2009 .
[67] Lakshmi B. Akella,et al. Diversity-Oriented Synthesis Approach to Macrocycles via Oxidative Ring Expansion , 2012, Nature chemical biology.
[68] A. Coyle,et al. HMGB1 and RAGE in inflammation and cancer. , 2010, Annual review of immunology.
[69] Stefan Wetzel,et al. Charting, navigating, and populating natural product chemical space for drug discovery. , 2012, Journal of medicinal chemistry.
[70] Sangmi Oh,et al. Construction of a polyheterocyclic benzopyran library with diverse core skeletons through diversity-oriented synthesis pathway. , 2010, Journal of combinatorial chemistry.
[71] S. Gabriel,et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. , 2008, Arthritis and rheumatism.
[72] R. Morphy. Selectively nonselective kinase inhibition: striking the right balance. , 2010, Journal of medicinal chemistry.
[73] Stuart L. Schreiber,et al. Organic chemistry: Molecular diversity by design , 2009, Nature.
[74] N. Mohamed,et al. Derivatized oxopiperazine rings from amino acids , 1997 .
[75] T. Tung,et al. Privileged substructure-based diversity-oriented synthesis pathway for diverse pyrimidine-embedded polyheterocycles. , 2013, Organic letters.
[76] M. Pittenger,et al. Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.
[77] S. Schreiber. PERSPECTIVE: THE SMALL-MOLECULE APPROACH TO BIOLOGYChemical genetics and diversity-oriented organic synthesis make possible the systematic exploration of biology , 2003 .
[78] M. Block,et al. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms , 2007, Nature Reviews Neuroscience.
[79] Derek S. Tan,et al. Diversity-oriented synthesis: exploring the intersections between chemistry and biology , 2005, Nature chemical biology.
[80] D. Newman,et al. Natural products as sources of new drugs over the last 25 years. , 2007, Journal of natural products.
[81] S. Ōmura,et al. Generation of anti-trypanosomal agents through concise synthesis and structural diversification of sesquiterpene analogues. , 2011, Journal of the American Chemical Society.
[82] Sun Wook Cho,et al. Discovery of a novel benzopyranyl compound as a potent in vitro and in vivo osteogenic agent , 2011 .
[83] Jongmin Park,et al. Development of a cy3-labeled glucose bioprobe and its application in bioimaging and screening for anticancer agents. , 2007, Angewandte Chemie.
[84] R. Strausberg,et al. From Knowing to Controlling: A Path from Genomics to Drugs Using Small Molecule Probes , 2003, Science.
[85] Tim Hardingham,et al. Tissue engineering: chondrocytes and cartilage , 2002, Arthritis research.
[86] Kyuho Han,et al. The imidazopyridine derivative JK184 reveals dual roles for microtubules in Hedgehog signaling. , 2009, Angewandte Chemie.
[87] S. Wetzel,et al. Biology-inspired synthesis of compound libraries , 2008, Cellular and Molecular Life Sciences.
[88] H. Waldmann,et al. Biology-oriented synthesis of stereochemically diverse natural-product-derived compound collections by iterative allylations on a solid support. , 2007, Chemistry.
[89] Sanghee Lee,et al. Discovery of novel benzopyranyl tetracycles that act as inhibitors of osteoclastogenesis induced by receptor activator of NF-κB ligand. , 2010, Journal of medicinal chemistry.
[90] P. Clemons,et al. Target identification and mechanism of action in chemical biology and drug discovery. , 2013, Nature chemical biology.
[91] B. E. Evans,et al. Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. , 1988, Journal of Medicinal Chemistry.
[92] L. Banaszynski,et al. A Rapid, Reversible, and Tunable Method to Regulate Protein Function in Living Cells Using Synthetic Small Molecules , 2006, Cell.
[93] S. Schreiber,et al. Target-oriented and diversity-oriented organic synthesis in drug discovery. , 2000, Science.
[94] Douglas A. Horton,et al. The combinatorial synthesis of bicyclic privileged structures or privileged substructures. , 2003, Chemical reviews.
[95] Herbert Waldmann,et al. Exploring and exploiting biologically relevant chemical space. , 2011, Current drug targets.
[96] J. Baldwin,et al. A new and efficient method for o-quinone methide intermediate generation: application to the biomimetic synthesis of the benzopyran derived natural products (+/-)-lucidene and (+/-)-alboatrin. , 2005, Organic & biomolecular chemistry.